Conference - United States
Now in its 14th year, the “Immunogenicity for Biotherapeutics” conference has witnessed the development of new classes of biomolecules from theory to blockbuster and has consistently been the site for state-of-the-art discussion and technical improvements in molecular safety and immunoprofiling.